S. Salvadeo

Effects of long chain ω-3 fatty acids on metalloproteinases and their inhibitors in combined dyslipidemia patients

A. D'Angelo, G. Derosa, P. Maffioli, 2009, Expert opinion on pharmacotherapy.

Effectsoflongchainω-3fatty acidsonmetalloproteinases andtheirinhibitorsincombined dyslipidemiapatients

G. Derosa, P. Maffioli, E. Fogari, 2009 .

Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin

A. D'Angelo, G. Derosa, P. Maffioli, 2010, Journal of clinical pharmacy and therapeutics.

Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone

A. D'Angelo, R. Fogari, G. Derosa, 2007, Journal of clinical pharmacy and therapeutics.

Metformin–pioglitazone and metformin–rosiglitazone effects on non‐conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome

A. D'Angelo, G. Derosa, S. Salvadeo, 2006, Journal of clinical pharmacy and therapeutics.

Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin

A. D'Angelo, G. Derosa, A. Cicero, 2007, Internal medicine journal.